New Horizons in Catalysis Europe Day Two
Friday 4 December 2009 - Conference Day Two
| 08.30 | Registration |
| | | Morning Session Chair: Dr Paul Alsters, DSM, The Netherlands |
|
| 08.25 | Opening Remarks
|
| 08.30 | Professor Mark Lautens, University of Toronto, Canada Synthesis and Reactions of Heterocycles: New Methods and Applications |
| 09.15 | Dr Craig Ruble, Eli Lilly & Co, USA Making Catalysis Simple |
| 10.00 | Dr Mandy Vink, Codexis Inc., USA The Development of a Biocatalysis-Based Approach to Sitagliptin |
| 10.45 | Coffee and Exhibition
|
| 11.30 | Dr Gerry Rassias, GlaxoSmithKline, UK Development of New Routes towards a Privileged Benzopyran Component Application to a 5HT4 Agonist |
| 12.15 | Dr Benoît Ledoussal, Novexel SA, France RuCl2 (bio-phosphine) (diamine)Stereo-catalytic Reduction in the Process Aiming at the Production of Multi-kilogram Quantity of cGMP NXL101 (Viquidacin) |
| 13.00 | Lunch and Exhibition
|
| | Afternoon Session Chair:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
, Scientific Update, UK |
| 14.00 | Professor Thomas J J Müller, Heinrich-Heine Universität Düsseldorf, Germany Palladium-Catalysed Generation of Alkynones, Alkenones and Allenes as an Entry to Multicomponent, Domino and Sequentially Catalysed Processes |
| 14.45 | Dr Michael Girgis, Novartis, USA Chemoselective O-Debenzylation at Low Hydrogen Partial Pressures: an Environmentally Benign Alternative to Transfer Hydrogenation |
| 15.30 | Conference Ends
|